Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Using sentiment indicators with index level data combines psychology and price to strengthen analysis. This overview provides steps to integrate both streams.
26,603 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Kraft Heinz pauses its planned breakup after a string of profit slips and a Berkshire Hathaway stake-shift. The move ...
Macy’s posts a stronger-than-expected Q4, lifting shares in a downbeat retail environment. The company leans into cre...
With a funding deadlock gripping the federal government, Trump’s border czar says ICE could be deployed to airport sc...
Barclays slashed Molson Coors' price target to $40, underscoring earnings headwinds as the brewer anticipates a tough...
Bookings are running below projections as the World Cup 2026 approaches. The shift could force price cuts, staffing c...
Financial planners warn that prioritizing 529s over retirement can jeopardize long-term security. This report explain...
Bakkt faces a pivotal year as crypto markets evolve and cash flow models mature. This guide explains what bakkt (bkkt...
Flyhomes has weathered a boom-bust housing cycle by recalibrating its business and embracing profitability over rapid...
In a move that stirs controversy, a $1.7 billion fund is being created to compensate allies in a settlement tied to T...
As inflation cools in 2026, Costco and Sprouts diverge on growth and valuation. This story weighs costco sprouts: whi...
The Federal Reserve is weighing a major shift to give crypto firms direct access to core settlement rails, potentiall...